Wednesday, July 8, 2026
🇺🇸 FDA

Drug profile · INN

fludeoxyglucose f-18

FLUDEOXYGLUCOSE F18

fludeoxyglucose f-18 (FLUDEOXYGLUCOSE F18) is a diagnostic agent. Associated with Chongqing Precision Biotech Co., Ltd. Route of administration: injection. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 20
Pipeline programs 7
News articles 0
Drug details — fludeoxyglucose f-18
US status
approved
Class
—
Route
INJECTION
Patents
20
Programs
7
Data quality
0.89
← All drugs Manufacturer profile Related patents Pipeline programs Drug news hub Event calendar

Quick answer

fludeoxyglucose f-18 (FLUDEOXYGLUCOSE F18) is a diagnostic agent. Associated with Chongqing Precision Biotech Co., Ltd. Route of administration: injection. Current US regulatory status: approved.

Key facts

INN fludeoxyglucose f-18
Brand FLUDEOXYGLUCOSE F18
Mechanism Diagnostic agent
Route INJECTION
Formulation INJECTABLE
Originator Chongqing Precision Biotech Co., Ltd

Mechanism of action

Diagnostic agent

Approval history

Authority Status Date
FDA approved —

Pipeline programs

Search pipeline Sponsor programs
  1. Glucose 5% 50 ml Phase 3 · Disc Medicine · Apnea of prematurity
  2. APHP200175 Phase 2 · PARItec · subarachnoid hemorrhages of aneurysmal origin (HSAa)
  3. 18F-FDG Phase 1 · First People's Hospital · Multiple Myeloma and Malignant Plasma Cell Neoplasms
  4. Glucose Phase 1 · United Therapeutics Europe · Diabetes Mellitus
  5. 18F-FDG Unknown · First People's Hospital · Tumor, Solid
  6. fludeoxyglucose F 18 Unknown · United Therapeutics Europe · Lung Cancer
  7. fludeoxyglucose F 18 Unknown · United Therapeutics Europe · Testicular Germ Cell Tumor

Related patents

Browse patents Chongqing Precision Biotech Co., Ltd patent hub

  1. US 12233135

    Therapeutic constructs for treating cancer

    Expires Mon Feb 20 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  2. US 12162920

    Hinge area and use of same in constructing car skeleton

    Expires Mon Dec 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  3. US 12054501

    Compositions and methods for inhibiting arginase activity

    Expires Mon Aug 01 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  4. US 11931453

    Drug delivery device

    Expires Mon Mar 14 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  5. US 11866747

    Engineered meganucleases that target human mitochondrial genomes

    Expires Mon Jan 04 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  6. US 11826392

    Purification method of fungal cell wall composition

    Expires Mon Nov 23 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  7. US 11490643

    Lactobacillus casei for treating obesity and associated metabolic disorders

    Expires Mon Nov 03 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  8. US 11317888

    Non-invasive method for pressure measurement

    Expires Mon Apr 28 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  9. US 11191935

    Implant delivery system with hydration promotor capability

    Expires Mon Dec 02 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  10. US 11129791

    Drug delivery device

    Expires Mon Sep 23 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  11. US 11078245

    Colon and pancreas cancer peptidomimetics

    Expires Mon Jul 29 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  12. US 10792481

    Implantable drug delivery device

    Expires Mon Oct 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  13. US 10662440

    Self-limiting viral vectors encoding nucleases

    Expires Mon May 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  14. US 10653169

    Food thickening agent, method for producing food thickening agent

    Expires Mon May 14 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  15. US 10533040

    Colon and pancreas cancer peptidomimetics

    Expires Mon Jan 09 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  16. US 10525248

    Apparatus and method for promoting fluid uptake into an implant

    Expires Mon Jan 02 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  17. US 10327461

    Food thickening agent, method for producing food thickening agent

    Expires Mon Jun 20 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  18. US 10214721

    Method for making culture medium

    Expires Mon Feb 21 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  19. US 10105523

    Implantable drug delivery device

    Expires Mon Oct 18 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

  20. US 10006052

    Laglidadg homing endonuclease cleaving the C-C chemokine receptor type-5 (CCR5) gene and uses thereof

    Expires Mon Jun 21 2038 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

What is fludeoxyglucose f-18?

fludeoxyglucose f-18 (FLUDEOXYGLUCOSE F18) is a diagnostic agent. Associated with Chongqing Precision Biotech Co., Ltd. Route of administration: injection. Current US regulatory status: approved.

What is the brand name for fludeoxyglucose f-18?

FLUDEOXYGLUCOSE F18 is a marketed brand name for fludeoxyglucose f-18. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of fludeoxyglucose f-18?

fludeoxyglucose f-18 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.